Systematic review of histological remission criteria in eosinophilic esophagitis
- PMID: 30483582
- PMCID: PMC6207047
- DOI: 10.1002/jgh3.12059
Systematic review of histological remission criteria in eosinophilic esophagitis
Abstract
Elemental diets, dietary elimination, and steroid therapies are the most common therapies in the clinical trials for eosinophilic esophagitis (EoE). Histological findings (usually reported as eosinophils per microscopic high-powered field [hpf]) remain the most common end-point used to define response. Yet, the threshold for defining "response" and "remission" are ill-defined among consensus guidelines and may vary from study to study. We conducted a systematic literature review of articles on eosinophilic esophagitis, published between January 2007 and November 2017, considering histological remission as the primary outcome. We abstracted treatment information and definitions of histological remission or response. A comparison of definitions of histological remission across and within institutions was performed. A total of 61 articles were included in this review, with approximately 60% of the studies published from centers in the United States. Histological definitions of remission of EoE ranged from 0 to ≤20 eosinophils/hpf. The most stringent criteria, ranging from 0 to ≤5 eosinophils/hpf, were commonly used in interventional trial studies that examined the effects of new treatments. We found remarkable variability in definitions between studies, treatment types, and regions. Age or epidemiological distribution of study subjects did not influence the criteria for histological remission. Clinical and histological improvements are important measures of the effects of treatment. Histological findings, the most objective measure of treatment, should provide an optimal method for comparing the effectiveness of various treatments. Yet, our findings suggest a lack of consistent remission criteria in published studies. Considering these inconsistencies, it is difficult to compare the effectiveness of various treatments.
Keywords: eosinophilic esophagitis; histological; improvement; remission; response; treatment; trial.
Figures
Similar articles
-
Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):210-216. doi: 10.1097/MPG.0000000000001952. J Pediatr Gastroenterol Nutr. 2018. PMID: 29509636
-
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.Aliment Pharmacol Ther. 2013 Nov;38(10):1312-9. doi: 10.1111/apt.12513. Epub 2013 Oct 5. Aliment Pharmacol Ther. 2013. PMID: 24117619 Clinical Trial.
-
The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis.Am J Gastroenterol. 2014 Apr;109(4):515-20. doi: 10.1038/ajg.2013.463. Epub 2014 Jan 21. Am J Gastroenterol. 2014. PMID: 24445569
-
Eosinophilic esophagitis: review of nonsurgical treatment modalities.Allergy Asthma Proc. 2013 Sep-Oct;34(5):421-6. doi: 10.2500/aap.2013.34.3690. Allergy Asthma Proc. 2013. PMID: 23998238 Review.
-
Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.Clin Gastroenterol Hepatol. 2018 Nov;16(11):1714-1729.e3. doi: 10.1016/j.cgh.2018.06.005. Epub 2018 Jun 14. Clin Gastroenterol Hepatol. 2018. PMID: 29908360
Cited by
-
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.Curr Allergy Asthma Rep. 2024 Jan;24(1):11-23. doi: 10.1007/s11882-023-01118-6. Epub 2023 Dec 12. Curr Allergy Asthma Rep. 2024. PMID: 38085499 Free PMC article. Review.
-
The use of amino acid-based nutritional feeds is effective in the dietary management of pediatric eosinophilic oesophagitis.Immun Inflamm Dis. 2019 Dec;7(4):292-303. doi: 10.1002/iid3.273. Epub 2019 Nov 6. Immun Inflamm Dis. 2019. PMID: 31692292 Free PMC article. Review.
-
Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis.Biomedicines. 2023 Dec 1;11(12):3204. doi: 10.3390/biomedicines11123204. Biomedicines. 2023. PMID: 38137426 Free PMC article. Review.
-
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes.Immunotargets Ther. 2024 Jul 24;13:367-383. doi: 10.2147/ITT.S276869. eCollection 2024. Immunotargets Ther. 2024. PMID: 39071859 Free PMC article. Review.
-
Eosinophilic esophagitis in children and adolescents: a clinical practice guideline.Ital J Pediatr. 2025 Jul 23;51(1):242. doi: 10.1186/s13052-025-02056-x. Ital J Pediatr. 2025. PMID: 40702503 Free PMC article.
References
-
- Liacouras CA, Spergel J, Gober LM. Eosinophilic esophagitis: Clinical presentation in children. Gastroenterol. Clin. North Am. 2014; 43: 219–29. - PubMed
-
- Liacouras CA, Furuta GT, Hirano I et al Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J. Allergy Clin. Immunol. 2011; 128: 3–20. - PubMed
-
- Furuta GT, Liacouras CA, Collins MH et al Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007; 133: 1342–63. - PubMed
Publication types
LinkOut - more resources
Full Text Sources